Počet záznamov: 1
LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis
SYS 0169317 LBL 00000naa--2200000-a-4500 005 20250607172521.7 008 201124s2020----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis / $c C. Xu ... [et al.] 300 $b ilustr., grafy, tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d010051 $a nádory vaječníkov $2 mesh 650 12
$7 sllk_us_auth*d062085 $a RNA dlhá nekódujúca $2 mesh 650 22
$7 sllk_us_auth*d051900 $a Smad3 proteín $2 mesh 650 22
$7 sllk_us_auth*d035683 $a mikroRNA $2 mesh 650 22
$7 sllk_us_auth*d014407 $a bunky nádorové kultivované $2 mesh 653 2-
$a lncRNA CDKN2B-AS1 (cyclin-dependent kinase inhibitor 2B antisense RNA1) 653 2-
$a miRNA-143-3p 653 2-
$a štúdia experimentálna 700 1-
$7 sllk_us_auth*0030652 $a Xu, C. $4 aut 773 0-
$7 nnas $w sllk_us_cat*0168806 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2020 $g Vol. 67, no. 4 (2020), s. 782-793
Počet záznamov: 1